Selected research
Market Structure
Global Androgenic Alopecia Therapeutics Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032
Market perspective
The global Androgenic Alopecia Therapeutics market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The US & Canada market for Androgenic Alopecia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The Europe market for Androgenic Alopecia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for Androgenic Alopecia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
The China market for Androgenic Alopecia Therapeutics is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global manufacturers of Androgenic Alopecia Therapeutics include Aclaris Therapeutics, Almirall, Astellas Pharma, BiologicsMD, Brickell Biotech, Cipla, Concert Pharmaceuticals, Reddy's Laboratories and RiverTown Therapeutics, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Includes
This report provides an overview of the global Androgenic Alopecia Therapeutics market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.
The study covers key producers of Androgenic Alopecia Therapeutics and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.
The report also presents Androgenic Alopecia Therapeutics revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.
In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the Androgenic Alopecia Therapeutics market size, projected growth trends, production technologies, key applications, and end-use industries.
Androgenic Alopecia Therapeutics Segment by Company
Aclaris Therapeutics
Almirall
Astellas Pharma
BiologicsMD
Brickell Biotech
Cipla
Concert Pharmaceuticals
Reddy's Laboratories
RiverTown Therapeutics
GlaxoSmithKline
Merck
Johnson & Johnson
Sun Pharma
Androgenic Alopecia Therapeutics Segment by Type
Medicine
Surgery
Other
Androgenic Alopecia Therapeutics Segment by Application
Hospital
Clinic
Other
Androgenic Alopecia Therapeutics Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Egypt
South Africa
Israel
Türkiye
GCC Countries
Study Objectives
1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.
3. To split the breakdown data by regions, type, manufacturers, and Application.
4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.
5. To identify significant trends, drivers, influence factors in global and regions.
6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Androgenic Alopecia Therapeutics market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Androgenic Alopecia Therapeutics and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market.
5. This report helps stakeholders to gain insights into which regions to target globally.
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Androgenic Alopecia Therapeutics.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of Androgenic Alopecia Therapeutics in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Androgenic Alopecia Therapeutics industry.
Chapter 3: Detailed analysis of Androgenic Alopecia Therapeutics companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Androgenic Alopecia Therapeuticsrevenue, gross margin, and recent development, etc.
Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.
Chapter 8: Europe by type, by application and by country, revenue for each segment.
Chapter 9: China by type, and by application, revenue for each segment.
Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.
Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.
Chapter 12: Concluding Insights of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- Medicine
- Surgery
- Other
Applications
- Hospital
- Clinic
- Other
Companies covered
- Aclaris Therapeutics
- Almirall
- Astellas Pharma
- BiologicsMD
- Brickell Biotech
- Cipla
- Concert Pharmaceuticals
- Reddy's Laboratories
- RiverTown Therapeutics
- GlaxoSmithKline
- Merck
- Johnson & Johnson
- Sun Pharma
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Market Analysis by Type
- 1.2.1 Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
- 1.2.2 Medicine
- 1.2.3 Surgery
- 1.2.4 Other
- 1.3 Market Analysis by Application
- 1.3.1 Global Androgenic Alopecia Therapeutics Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
- 1.3.2 Hospital
- 1.3.3 Clinic
- 1.3.4 Other
- 1.4 Global Market Growth Prospects
- 1.5 Global Androgenic Alopecia Therapeutics Growth Trends by Region
- 1.5.1 Global Androgenic Alopecia Therapeutics Market Size by Region: 2021 VS 2025 VS 2032
- 1.5.2 Androgenic Alopecia Therapeutics Market Size by Region (2021-2026)
- 1.5.3 Androgenic Alopecia Therapeutics Market Size by Region (2027-2032)
- 1.6 Assumptions and Limitations
- 1.7 Study Goals and Objectives
- 1.8 Years Considered
2 Global Androgenic Alopecia Therapeutics Market Dynamics
- 2.1 Androgenic Alopecia Therapeutics Industry Trends
- 2.2 Androgenic Alopecia Therapeutics Industry Drivers
- 2.3 Androgenic Alopecia Therapeutics Industry Opportunities and Challenges
- 2.4 Androgenic Alopecia Therapeutics Industry Restraints
3 Competitive Landscape by Company
- 3.1 Global Androgenic Alopecia Therapeutics Revenue by Company (2021-2026)
- 3.2 Global Androgenic Alopecia Therapeutics Players Revenue Ranking, 2024 VS 2025 VS 2026
- 3.3 Global Androgenic Alopecia Therapeutics Key Company Head office and Area Served
- 3.4 Global Androgenic Alopecia Therapeutics Company, Product Type & Application
- 3.5 Global Androgenic Alopecia Therapeutics Company Establishment Date
- 3.6 Market Competitive Analysis
- 3.6.1 Global Androgenic Alopecia Therapeutics Market CR5 and HHI
- 3.6.2 Global Top 5 and 10 Androgenic Alopecia Therapeutics Players Market Share by Revenue in 2025
- 3.6.3 2025 Androgenic Alopecia Therapeutics Tier 1, Tier 2, and Tier 3
4 Androgenic Alopecia Therapeutics Market by Type
- 4.1 Global Androgenic Alopecia Therapeutics Market Size by Type (2021 VS 2025 VS 2032)
- 4.2 Global Androgenic Alopecia Therapeutics Market Size by Type (2021-2032)
- 4.3 Global Androgenic Alopecia Therapeutics Market Size Share by Type (2021-2032)
5 Androgenic Alopecia Therapeutics Market by Application
- 5.1 Global Androgenic Alopecia Therapeutics Market Size by Application (2021 VS 2025 VS 2032)
- 5.2 Global Androgenic Alopecia Therapeutics Market Size by Application (2021-2032)
- 5.3 Global Androgenic Alopecia Therapeutics Market Size Share by Application (2021-2032)
6 Company Profiles
- 6.1 Aclaris Therapeutics
- 6.1.1 Aclaris Therapeutics Company Information
- 6.1.2 Aclaris Therapeutics Business Overview
- 6.1.3 Aclaris Therapeutics Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.1.4 Aclaris Therapeutics Androgenic Alopecia Therapeutics Product Portfolio
- 6.1.5 Aclaris Therapeutics Recent Developments
- 6.2 Almirall
- 6.2.1 Almirall Company Information
- 6.2.2 Almirall Business Overview
- 6.2.3 Almirall Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.2.4 Almirall Androgenic Alopecia Therapeutics Product Portfolio
- 6.2.5 Almirall Recent Developments
- 6.3 Astellas Pharma
- 6.3.1 Astellas Pharma Company Information
- 6.3.2 Astellas Pharma Business Overview
- 6.3.3 Astellas Pharma Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.3.4 Astellas Pharma Androgenic Alopecia Therapeutics Product Portfolio
- 6.3.5 Astellas Pharma Recent Developments
- 6.4 BiologicsMD
- 6.4.1 BiologicsMD Company Information
- 6.4.2 BiologicsMD Business Overview
- 6.4.3 BiologicsMD Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.4.4 BiologicsMD Androgenic Alopecia Therapeutics Product Portfolio
- 6.4.5 BiologicsMD Recent Developments
- 6.5 Brickell Biotech
- 6.5.1 Brickell Biotech Company Information
- 6.5.2 Brickell Biotech Business Overview
- 6.5.3 Brickell Biotech Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.5.4 Brickell Biotech Androgenic Alopecia Therapeutics Product Portfolio
- 6.5.5 Brickell Biotech Recent Developments
- 6.6 Cipla
- 6.6.1 Cipla Company Information
- 6.6.2 Cipla Business Overview
- 6.6.3 Cipla Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.6.4 Cipla Androgenic Alopecia Therapeutics Product Portfolio
- 6.6.5 Cipla Recent Developments
- 6.7 Concert Pharmaceuticals
- 6.7.1 Concert Pharmaceuticals Company Information
- 6.7.2 Concert Pharmaceuticals Business Overview
- 6.7.3 Concert Pharmaceuticals Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.7.4 Concert Pharmaceuticals Androgenic Alopecia Therapeutics Product Portfolio
- 6.7.5 Concert Pharmaceuticals Recent Developments
- 6.8 Reddy's Laboratories
- 6.8.1 Reddy's Laboratories Company Information
- 6.8.2 Reddy's Laboratories Business Overview
- 6.8.3 Reddy's Laboratories Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.8.4 Reddy's Laboratories Androgenic Alopecia Therapeutics Product Portfolio
- 6.8.5 Reddy's Laboratories Recent Developments
- 6.9 RiverTown Therapeutics
- 6.9.1 RiverTown Therapeutics Company Information
- 6.9.2 RiverTown Therapeutics Business Overview
- 6.9.3 RiverTown Therapeutics Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.9.4 RiverTown Therapeutics Androgenic Alopecia Therapeutics Product Portfolio
- 6.9.5 RiverTown Therapeutics Recent Developments
- 6.10 GlaxoSmithKline
- 6.10.1 GlaxoSmithKline Company Information
- 6.10.2 GlaxoSmithKline Business Overview
- 6.10.3 GlaxoSmithKline Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.10.4 GlaxoSmithKline Androgenic Alopecia Therapeutics Product Portfolio
- 6.10.5 GlaxoSmithKline Recent Developments
- 6.11 Merck
- 6.11.1 Merck Company Information
- 6.11.2 Merck Business Overview
- 6.11.3 Merck Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.11.4 Merck Androgenic Alopecia Therapeutics Product Portfolio
- 6.11.5 Merck Recent Developments
- 6.12 Johnson & Johnson
- 6.12.1 Johnson & Johnson Company Information
- 6.12.2 Johnson & Johnson Business Overview
- 6.12.3 Johnson & Johnson Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.12.4 Johnson & Johnson Androgenic Alopecia Therapeutics Product Portfolio
- 6.12.5 Johnson & Johnson Recent Developments
- 6.13 Sun Pharma
- 6.13.1 Sun Pharma Company Information
- 6.13.2 Sun Pharma Business Overview
- 6.13.3 Sun Pharma Androgenic Alopecia Therapeutics Revenue and Gross Margin (US$ Million) & (2021-2026)
- 6.13.4 Sun Pharma Androgenic Alopecia Therapeutics Product Portfolio
- 6.13.5 Sun Pharma Recent Developments
7 North America
- 7.1 North America Androgenic Alopecia Therapeutics Market Size (2021-2032)
- 7.2 North America Androgenic Alopecia Therapeutics Market Size by Type
- 7.2.1 North America Androgenic Alopecia Therapeutics Market Size by Type (2021-2026)
- 7.2.2 North America Androgenic Alopecia Therapeutics Market Size by Type (2027-2032)
- 7.2.3 North America Androgenic Alopecia Therapeutics Market Share by Type (2021-2032)
- 7.3 North America Androgenic Alopecia Therapeutics Market Size by Application
- 7.3.1 North America Androgenic Alopecia Therapeutics Market Size by Application (2021-2026)
- 7.3.2 North America Androgenic Alopecia Therapeutics Market Size by Application (2027-2032)
- 7.3.3 North America Androgenic Alopecia Therapeutics Market Share by Application (2021-2032)
- 7.4 North America Androgenic Alopecia Therapeutics Market Size by Country
- 7.4.1 North America Androgenic Alopecia Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
- 7.4.2 North America Androgenic Alopecia Therapeutics Market Size by Country (2021-2026)
- 7.4.3 North America Androgenic Alopecia Therapeutics Market Size by Country (2027-2032)
- 7.4.4 North America Androgenic Alopecia Therapeutics Market Share by Country (2021-2032)
- 7.4.5 United States
- 7.4.6 Canada
- 7.4.7 Mexico
8 Europe
- 8.1 Europe Androgenic Alopecia Therapeutics Market Size (2021-2032)
- 8.2 Europe Androgenic Alopecia Therapeutics Market Size by Type
- 8.2.1 Europe Androgenic Alopecia Therapeutics Market Size by Type (2021-2026)
- 8.2.2 Europe Androgenic Alopecia Therapeutics Market Size by Type (2027-2032)
- 8.2.3 Europe Androgenic Alopecia Therapeutics Market Share by Type (2021-2032)
- 8.3 Europe Androgenic Alopecia Therapeutics Market Size by Application
- 8.3.1 Europe Androgenic Alopecia Therapeutics Market Size by Application (2021-2026)
- 8.3.2 Europe Androgenic Alopecia Therapeutics Market Size by Application (2027-2032)
- 8.3.3 Europe Androgenic Alopecia Therapeutics Market Share by Application (2021-2032)
- 8.4 Europe Androgenic Alopecia Therapeutics Market Size by Country
- 8.4.1 Europe Androgenic Alopecia Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
- 8.4.2 Europe Androgenic Alopecia Therapeutics Market Size by Country (2021-2026)
- 8.4.3 Europe Androgenic Alopecia Therapeutics Market Size by Country (2027-2032)
- 8.4.4 Europe Androgenic Alopecia Therapeutics Market Share by Country (2021-2032)
- 8.4.5 Germany
- 8.4.6 France
- 8.4.7 U.K.
- 8.4.8 Italy
- 8.4.9 Russia
- 8.4.10 Nordic Countries
9 China
- 9.1 China Androgenic Alopecia Therapeutics Market Size (2021-2032)
- 9.2 China Androgenic Alopecia Therapeutics Market Size by Type
- 9.2.1 China Androgenic Alopecia Therapeutics Market Size by Type (2021-2026)
- 9.2.2 China Androgenic Alopecia Therapeutics Market Size by Type (2027-2032)
- 9.2.3 China Androgenic Alopecia Therapeutics Market Share by Type (2021-2032)
- 9.3 China Androgenic Alopecia Therapeutics Market Size by Application
- 9.3.1 China Androgenic Alopecia Therapeutics Market Size by Application (2021-2026)
- 9.3.2 China Androgenic Alopecia Therapeutics Market Size by Application (2027-2032)
- 9.3.3 China Androgenic Alopecia Therapeutics Market Share by Application (2021-2032)
10 Asia (Excluding China)
- 10.1 Asia Androgenic Alopecia Therapeutics Market Size (2021-2032)
- 10.2 Asia Androgenic Alopecia Therapeutics Market Size by Type
- 10.2.1 Asia Androgenic Alopecia Therapeutics Market Size by Type (2021-2026)
- 10.2.2 Asia Androgenic Alopecia Therapeutics Market Size by Type (2027-2032)
- 10.2.3 Asia Androgenic Alopecia Therapeutics Market Share by Type (2021-2032)
- 10.3 Asia Androgenic Alopecia Therapeutics Market Size by Application
- 10.3.1 Asia Androgenic Alopecia Therapeutics Market Size by Application (2021-2026)
- 10.3.2 Asia Androgenic Alopecia Therapeutics Market Size by Application (2027-2032)
- 10.3.3 Asia Androgenic Alopecia Therapeutics Market Share by Application (2021-2032)
- 10.4 Asia Androgenic Alopecia Therapeutics Market Size by Country
- 10.4.1 Asia Androgenic Alopecia Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
- 10.4.2 Asia Androgenic Alopecia Therapeutics Market Size by Country (2021-2026)
- 10.4.3 Asia Androgenic Alopecia Therapeutics Market Size by Country (2027-2032)
- 10.4.4 Asia Androgenic Alopecia Therapeutics Market Share by Country (2021-2032)
- 10.4.5 Japan
- 10.4.6 South Korea
- 10.4.7 Taiwan
- 10.4.8 Southeast Asia
- 10.4.9 India
- 10.4.10 Australia
11 South America, Middle East & Africa
- 11.1 South America, Middle East & Africa Androgenic Alopecia Therapeutics Market Size (2021-2032)
- 11.2 South America, Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type
- 11.2.1 South America, Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type (2021-2026)
- 11.2.2 South America, Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Type (2027-2032)
- 11.2.3 South America, Middle East & Africa Androgenic Alopecia Therapeutics Market Share by Type (2021-2032)
- 11.3 South America, Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application
- 11.3.1 South America, Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application (2021-2026)
- 11.3.2 South America, Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Application (2027-2032)
- 11.3.3 South America, Middle East & Africa Androgenic Alopecia Therapeutics Market Share by Application (2021-2032)
- 11.4 South America, Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country
- 11.4.1 South America, Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2021 VS 2025 VS 2032)
- 11.4.2 South America, Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2021-2026)
- 11.4.3 South America, Middle East & Africa Androgenic Alopecia Therapeutics Market Size by Country (2027-2032)
- 11.4.4 South America, Middle East & Africa Androgenic Alopecia Therapeutics Market Share by Country (2021-2032)
- 11.4.5 Brazil
- 11.4.6 South Africa
- 11.4.7 Saudi Arabia
- 11.4.8 Turkey
- 11.4.9 Argentina
- 11.4.9 UAE
- 11.4.9 Egypt
- 11.4.9 Chile
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
- 13.6 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst